Reconstituted 5-Amino-1MQ must be used within 28 days when refrigerated at 28C
Bottom line Retatrutide is a triple-action peptide, emerging as a new weight loss medication with greater efficacy than existing medications
Article 12 mins Navigating AI-Related Risks: A Guide for Directors and Officers As AI evolves, directors and officers must maneuver through a complex landscape of regulatory and legal risks
Media contact Andrea Barsk-Roberts CMO, BodySpec [email protected] 347-749-2062 References: Wilding JPH, Batterham RL, Calanna S, et al
En ensayos clnicos como SURPASS y SURMOUNT, la tirzepatida ha mostrado reducciones significativas de hemoglobina A1c (hasta 2.0-2.5% con dosis de 15 mg) y prdida de peso sustancial (15-22% del peso corporal inicial en estudios de 72 semanas), adems de mejoras en factores de riesgo cardiometablico como presin arterial y perfil lipdico